This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
How is Burlington Stores (BURL) Placed Before Q4 Earnings?
by Zacks Equity Research
The coronavirus pandemic might profoundly impact Burlington Stores' (BURL) fourth-quarter fiscal 2020 results.
Grocery Outlet (GO) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Grocery Outlet's (GO) fourth-quarter 2020 results might reflect gains from coronavirus-led demand. Moreover, its business model and strategic endeavors remain impressive.
B&G Foods (BGS) Lined Up for Q4 Earnings: Key Things to Note
by Zacks Equity Research
B&G Foods' (BGS) fourth-quarter 2020 results are likely to reflect increased demand stemming from pandemic-led higher at-home consumption.
ACI vs. PRPL: Which Stock Is the Better Value Option?
by Zacks Equity Research
ACI vs. PRPL: Which Stock Is the Better Value Option?
Inter Parfums (IPAR) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Positive impact of cost-containment efforts is likely to get reflected in Inter Parfums' (IPAR) fourth-quarter 2020 performance.
Beyond Meat (BYND) to Report Q4 Earnings: Key Things to Note
by Zacks Equity Research
Beyond Meat's (BYND) fourth-quarter 2020 results are likely to reflect weak foodservice revenues due to pandemic-led restrictions on several customers of the company.
Medifast (MED) Lined Up for Q4 Earnings: Key Things to Note
by Zacks Equity Research
Medifast's (MED) fourth-quarter 2020 results are likely to reflect strength in OPTAVIA, thanks to consumers' growing inclination toward health and wellness.
ACI or PRPL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ACI vs. PRPL: Which Stock Is the Better Value Option?
Will Purple Innovation (PRPL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Purple Innovation (PRPL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ACI vs. PRPL: Which Stock Is the Better Value Option?
by Zacks Equity Research
ACI vs. PRPL: Which Stock Is the Better Value Option?
ACI or PRPL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ACI vs. PRPL: Which Stock Is the Better Value Option?
Purple Innovation (PRPL) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Purple Innovation (PRPL) delivered earnings and revenue surprises of 8.00% and 6.01%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Why Purple Innovation (PRPL) Could Beat Earnings Estimates Again
by Zacks Equity Research
Purple Innovation (PRPL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should You Buy Purple Innovation (PRPL) Ahead of Earnings?
by Zacks Equity Research
Purple Innovation (PRPL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ADRNY vs. PRPL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ADRNY vs. PRPL: Which Stock Is the Better Value Option?
5 Consumer Staple Stocks Poised for a Beat This Earnings Season
by Vrishali Bagree
Rising demand aids consumer staple players amid pandemic. Hershey (HSY), Tyson Foods (TSN), Grocery Outlet (GO), Energizer Holdings (ENR) and Purple Innovation (PRPL) are set to tap the opportunities.
Purple Innovation (PRPL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Purple Innovation (PRPL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Beyond Meat (BYND) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Beyond Meat's (BYND) third-quarter results are likely to reflect gains in the retail business due to pandemic-led higher at-home consumption. The foodservice business is likely to remain soft.
How Purple Innovation (PRPL) Looks Just Ahead of Q3 Earnings
by Zacks Equity Research
Purple Innovation's (PRPL) third-quarter 2020 performance is likely to have gained from higher demand for products like mattresses as well as growth in online transactions.
Is Hershey (HSY) Poised to Beat Earnings Estimate in Q3?
by Zacks Equity Research
Strong sales in the North America unit on higher at-home consumption, sales recovery in food service and specialty retail networks, price realization are likely to have aided Hershey's (HSY) Q3 sales.
Factors Likely to Influence TreeHouse Foods' (THS) Q3 Earnings
by Zacks Equity Research
TreeHouse Foods' (THS) third-quarter 2020 results are likely to gain from increased demand and greater at-home consumption. However, high costs and a soft Food Away From Home business are concerning.
Is Monster Beverage (MNST) Poised for an Earnings Beat in Q3?
by Zacks Equity Research
Monster Beverage (MNST) is likely to have gained from solid energy drinks business, improved at-home consumption trends and online demand in Q3. Cost leverage is likely to have aided earnings.
All You Need to Note Before B&G Foods' (BGS) Q3 Earnings
by Zacks Equity Research
B&G Foods' (BGS) third-quarter results are likely to reflect increased demand from pandemic-led higher at-home consumption. This is likely to have helped counter soft away-from-home food demand.
Things You Should Know About Clorox (CLX) Ahead of Q1 Earnings
by Zacks Equity Research
Clorox's (CLX) Q1 top line is likely to have gained from continued strong product demand and growth across segments. Higher costs and investments to meet demand are likely to have hurt margins.
Purple Innovation (PRPL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Purple Innovation (PRPL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.